United Therapeutics (Germany) Investor Sentiment

UTH Stock  EUR 352.40  6.20  1.79%   
Roughly 55% of United Therapeutics' stockholders are presently thinking to get in. The analysis of current outlook of investing in United Therapeutics suggests that some traders are interested regarding United Therapeutics' prospects. The current market sentiment, together with United Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use United Therapeutics stock news signals to limit their universe of possible portfolio assets.
United Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of United daily returns and investor perception about the current price of United Therapeutics as well as its diversification or hedging effects on your existing portfolios.
  
over a week ago at news.google.com         
United Therapeutics president sells 3.65 million in stock - Investing.com
Google News at Macroaxis
over two weeks ago at news.google.com         
UBS Group Increases United Therapeutics Price Target to 475.00 - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
CWA Asset Management Group LLC Makes New Investment in United Therapeutics Co. - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
Why United Therapeutics is a Top Growth Stock for the Long-Term - Yahoo Finance
Google News at Macroaxis
over a month ago at news.google.com         
1000 Invested In United Therapeutics 20 Years Ago Would Be Worth This Much Today - Benzinga
Google News at Macroaxis
over a month ago at news.google.com         
Brophy Wealth Management LLC Acquires New Stake in United Therapeutics Co. - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
True Wealth Design LLC Reduces Position in United Therapeutics Co. - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
The 3.8 percent return this week takes United Therapeutics shareholders five-year gains to 314 perce...
Google News at Macroaxis
over a month ago at news.google.com         
Connor Clark Lunn Investment Management Ltd. Reduces Stock Position in United Therapeutics Co. - Mar...
Google News at Macroaxis
over two months ago at news.google.com         
Zacks Research Issues Positive Forecast for UTHR Earnings - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
Have Insiders Sold United Therapeutics Shares Recently - Simply Wall St
Google News at Macroaxis
over two months ago at news.google.com         
United Therapeutics - One To Believe In Despite Competitive Threats - Seeking Alpha
Google News at Macroaxis
over two months ago at news.google.com         
United Therapeutics to Present at UBS Healthcare Conference Key Updates Coming UTHR Stock News - Sto...
Google News at Macroaxis
over three months ago at news.google.com         
United Therapeutics Up 9.9 percent Since Last Earnings Report Can It Continue - MSN
Google News at Macroaxis
over three months ago at news.google.com         
United Therapeutics Shares Thrive - Yahoo Finance
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about United Therapeutics that are available to investors today. That information is available publicly through United media outlets and privately through word of mouth or via United internal channels. However, regardless of the origin, that massive amount of United data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of United Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of United Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to United Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive United Therapeutics alpha.

United Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for United Stock analysis

When running United Therapeutics' price analysis, check to measure United Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Therapeutics is operating at the current time. Most of United Therapeutics' value examination focuses on studying past and present price action to predict the probability of United Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Therapeutics' price. Additionally, you may evaluate how the addition of United Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk